ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 022,41
-0,01%
Dow Jones
37 986,40
0,56%
DAX
17 737,36
-0,64%
Brent Oil
86,625
0,00%
Bitcoin
63 775,10
-0,08%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Novartis AG (NVS)

  7. Novartis AG (NVS) Actualités

NVS Novartis AG

94,36
1,79 (1,93%)
20 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Novartis AG NVS NYSE Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
1,79 1,93% 94,36 01:47:25
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
93,20 93,15 94,495 94,36 92,57
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
15/4/202420:00PRNUSNew Novartis Fabhalta® (iptacopan) data show clinically..
11/4/202413:00GLOBEArvinas Enters into a Transaction with Novartis, including a..
10/4/202413:13IHMARKETNEWSDelta Generates US$37 Million Profit in Q1, Google and Intel..
06/4/202422:16PRNUSNew Novartis data show early addition of twice-yearly*..
15/2/202422:15EDGAR2Form S-8 POS - Securities to be offered to employees in..
06/2/202422:52EDGAR2Form SC TO-C - Written communication relating to an issuer..
06/2/202412:14IHMARKETNEWSBoeing Faces Strike Threat, Palantir Up 18% After Recording..
05/2/202423:06EDGAR2Form SC TO-C - Written communication relating to an issuer..
02/2/202420:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202413:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202413:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202413:42EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
31/1/202413:38EDGAR2Form 20-F - Annual and transition report of foreign private..
31/1/202412:28IHMARKETNEWSWalmart’s Stock Split, Elon Musk’s Billion-Dollar Package..
22/1/202407:59DJNSandoz to Acquire Cimerli Business from Coherus for $170..
12/1/202412:10IHMARKETNEWSWall Street Highlights: DocuSign Acquisition Battle, Tesla..
11/1/202419:15DJFRNovartis pourrait renoncer à un rachat de Cytokinetics -..
11/1/202419:02DJNCytokinetics Shares Slide as Novartis Reportedly Shies Away..
09/1/202410:01DJFRGSK achète Aiolos, spécialisé dans les maladies..
08/1/202420:22DJFRNovartis en négociations avancées pour racheter la société..
08/1/202419:43DJNCytokinetics Shares Jump 16% After WSJ Report of Novartis..
08/1/202416:41DJNNovartis on Track for Record High Close -- Data Talk
08/1/202412:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202408:01DJNNovartis's Scemblix Drug Meets Main Goals in Late-Stage..
05/1/202416:15DJNNovartis to Make Pluvicto Radioligand Therapy at..
02/1/202413:46DJNVoyager Therapeutics Shares Leap Premarket on Novartis..
11/12/202312:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202308:02DJNNovartis Drug Meets Primary Goal in Late-Stage Study for..
11/12/202301:39PRNUSNovartis presents new 48-week results from Phase III..
06/12/202312:18DJFRBOURSE: Merck KGaA chute après l'échec de deux essais sur un..
06/12/202311:14DJNMerck Shares Slump After Multiple Sclerosis Drug Fails in..
06/12/202306:18PRNUSNovartis receives FDA approval for Fabhalta® (iptacopan),..
05/12/202312:25IHMARKETNEWSMoody’s Reassesses China, GitLab Exceeds Estimates, Twilio..
29/11/202312:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
28/11/202321:08DJNFDA Looking Into All Approved CAR T Therapies on Risk of..
28/11/202312:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202308:41DJFRNovartis relève son objectif de croissance du chiffre..
28/11/202308:12DJNNovartis Raises Mid-Term Sales Growth Targets
13/11/202315:16DJNLegend Biotech Subsidiary in License Agreement With Novartis
01/11/202313:45IHNWGet Ready for Next Generation of Diabetes, Weight-Management..
01/11/202307:43DJNNovartis Skin Treatment Drug Cosentyx Gets US FDA Approval
30/10/202311:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202308:07DJNNovartis to Seek US Accelerated Approval of Atrasentan After..
27/10/202307:45DJNNovartis Says FDA Deems Pluvicto Shortage Resolved, Supply..
24/10/202313:22IHMARKETNEWSTuesday’s Wall Street Highlights: Coinbase, Intel, Redfin,..
24/10/202312:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202309:32DJNNovartis Raises Earnings Guidance Again After Key Drugs..
24/10/202308:52DJFRNovartis relève ses objectifs pour 2023 après la hausse de..
24/10/202307:48DJNNovartis Raises Earnings Guidance After Key Drugs Boost..
06/10/202323:11DJNNovartis Gets FDA Approval IV Formulation of Cosentyx

Dernières Valeurs Consultées

NYSE
NVS
Novartis
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés